Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease

Original Article

The EMPA-KIDNEY Collaborative Group

N Engl J Med 2025;392:777-787

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
02/19/2025
Course expires: 
02/20/2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.